Is bladder tumor serious?

Bladder tumor is the most common tumor of the urinary system and one of the most common tumors in the body. Most of them occur in the triangle area, the two side walls and the neck. The cause of bladder tumor is complicated. Although it has been studied a lot, it is still not completely clear. Its early symptoms are not obvious, such as frequent urination and painful urination, which are often ignored by patients. So, is bladder tumor serious? How to treat it to recover?

Bladder tumors are mostly distributed in the lateral and posterior walls of the bladder, followed by the triangular area and the top. They can occur in multiple foci and can be accompanied by tumors of the renal pelvis, ureter and urethra at the same time or successively. The spread of bladder tumors is mainly deep infiltration, followed by distant metastasis. The main metastatic pathways are the iliac lymph nodes and abdominal aortic lymph nodes. In the late stage, a small number of patients can metastasize to the lungs, bones, liver and other organs through the bloodstream. The metastasis of bladder cancer occurs later and spreads more slowly.

Bladder tumors, like other tumors, are divided into benign and malignant. The treatment plans adopted vary according to the patient's condition, onset time, and tumor size, but some patients are mainly treated with surgery. Surgical treatment is divided into transurethral surgery, cystotomy tumor resection, partial cystectomy, and total cystectomy. Different treatment methods should be selected according to the location, infiltration depth, number, malignancy of the tumor, and the patient's general condition. Radiotherapy and chemotherapy are auxiliary treatments.

Bladder tumors are prone to recurrence after resection, but recurrences may still be cured. For all surgical treatments that preserve the bladder, more than half will recur within 2 years. The recurrence is often not in the original location, but is actually a new tumor, and 10% to 15% have a tendency to increase in malignancy. Therefore, any patient who undergoes surgery to preserve the bladder should be closely followed up, with a cystoscopic examination every 3 months. If there is no recurrence within 1 year, the review time should be extended as appropriate. This review should be part of the treatment. 50% to 70% of patients with superficial bladder tumors will recur within 1 year after surgery, and 10% to 30% will continue to progress to invasive lesions. Once the tumor invades the deep muscle layer, most patients have a poor prognosis.

Bladder tumors are actually not scary. As long as they are discovered, diagnosed and treated early, the cure rate is still very high. In addition, patients should strengthen labor protection, reduce contact with exogenous carcinogens, drink more water and urinate in time, which may play a certain preventive role. For patients who have undergone surgical treatment, intrabladder drug instillation and regular follow-up cystoscopy are very important for preventing recurrence.